Articles tagged "Outcome"

2020 American Transplant Congress
Trends in Intestinal and Multivisceral Transplantation in the United States over 30 Years
M. L. Samoylova¹, J. Yerxa¹, B. I. Shaw¹, S. Horslen², S. Jafri³, A. Mavis⁴, T. Schiano⁵, B. Summers⁶, A. S. Barbas¹, D. L. Sudan¹, M. C. Segovia⁴
¹Surgery, Duke University Hospital, Durham, NC, ²Ped Gastroenterology, Seattle Childrens' Hospital, Seattle, WA, ³Gastroenterology, Henry Ford Hospital, Detroit, MI, ⁴Gastroenterology, Duke University Hospital, Durham, NC, ⁵Gastroenterology, Mt Sinai Hospital, New York, NY, ⁶Transplant Pharmacy, Henry Ford Hospital, Detroit, MI
*Purpose: We describe trends in intestinal transplantation use and outcomes over time in the USA.*Methods: We use the cohort of intestinal and multivisceral transplants 1990-2019…
2020 American Transplant Congress
Proposed New Pancreas Allocation Policy: Moving to Concentric Circles as First Unit of Allocation
A. Israni¹, S. Gustafson¹, B. Thompson¹, A. Wey¹, S. Niederhaus², R. Forbes³, A. Fox⁴, B. Kasiske¹, J. Snyder¹
¹SRTR, Minneapolis, MN, ²Univ of Maryland, Baltimore, MD, ³Vanderbilt Univ, Nashville, TN, ⁴UNOS, Richmond, VA
*Purpose: The Organ Procurement and Transplantation Network (OPTN) proposed a new national deceased donor pancreas allocation policy that removes donor service area and OPTN region…
2020 American Transplant Congress
History of Coronary Artery Disease Predicts Inferior Survival in Liver Transplant Recipients of Advanced Age in a Large Multicenter U.S. Cohort
M. German¹, A. Hristov¹, A. Lee¹, F. Osman¹, A. Kwong², D. Devuni³, C. Wang⁴, J. Boike⁵, J. Jo⁵, L. VanWagner⁵, M. Serper⁶, R. Sharma⁷, E. Verna⁷, J. Shor³, A. Koteish⁸, G. Sehmbey⁹, A. Seetharam⁹, N. John², Y. Patel¹⁰, M. Kappus¹⁰, T. Couri¹¹, S. Paul¹¹, R. Salgia¹², Q. Nhu¹³, C. Frenette¹³, J. Lai⁴, A. Goel², E. Spengler¹
¹U of Wisconsin, Madison, WI, ²Stanford, Palo Alto, CA, ³U of Massachusetts, Worcester, MA, ⁴U of California, San Francisco, CA, ⁵Northwestern, Chicago, IL, ⁶U of Pennsylvania, Philadelphia, PA, ⁷Columbia, New York, NY, ⁸Florida Hospital, Orlando, FL, ⁹U of Arizona, Phoenix, AZ, ¹⁰Duke, Durham, NC, ¹¹U of Chicago, Chicago, IL, ¹²Henry Ford Hospital, Detroit, MI, ¹³Scripps, San Diego, CA
*Purpose: Coronary artery disease (CAD) is common in patients of advanced age and does not preclude liver transplantation (LT) if adequately treated. We aimed to…
2020 American Transplant Congress
Hepatitis C-Infected Donors and Hepatitis C-Infected Recipients: Analysis of Renal Transplant Outcomes
H. Crossman¹, M. Tavakol², C. Freise², P. Chin-Hong³
¹Internal Medicine Residency Program, UCSF, San Francisco, CA, ²Surgery, UCSF, San Francisco, CA, ³Infectious Disease, UCSF, San Francisco, CA
*Purpose: Increased utilization of hepatitis C virus infected organs could reduce the supply demand mismatch in organ transplantation. At this time, there is little data…
2020 American Transplant Congress
Graft versus Host Disease in Liver Transplant Recipients: A Case Series
N. Joiner, J. Dietz, K. Nava-Estevanott, L. Kerbe
Cleveland Clinic Florida, Weston, FL
*Purpose: Graft Versus Host Disease (GvHD) is a serious and potentially fatal disease that is rarely observed in solid organ transplant recipients; however, we report…
2020 American Transplant Congress
Hepatocyte Growth Factor (HGF) Prevents the Apoptotic and Anti-Angiogenic Effect of Hypercholesterolemia on Hepatocytes in Liver Allografts
H. B. Ozdemir¹, G. Ozgun¹, A. Yucel Polat¹, N. Haberal¹, G. Moray², M. Haberal²
¹Pathology, Baskent University, Ankara, Turkey, ²Department of General Surgery, Division of Transplantation, Baskent University, Ankara, Turkey
*Purpose: Background: Hypercholesterolemia (HC) impairs angiogenesis and induces apoptosis in livers. This hyperlipidemic impairment of angiogenesis reported associated with reduced bFGF. HGF stimulates proliferation, angiogenesis,…
2020 American Transplant Congress
Medication Adherence Assessment Findings in Kidney Transplant Candidates Undergoing Living Donor Transplant
J. Trofe-Clark¹, G. Malat¹, M. Norris¹, D. Sawinski², M. Bleicher², R. Bloom²
¹Hosp of Univ of Pennsylvania, Philadelphia, PA, ²Renal Div, Univ of Pennsylvania, Philadelphia, PA
*Purpose: Medication adherence is key to kidney transplant (KTx) success. Our center implemented standardized medication adherence assessment and education in KTx candidates undergoing living donor…
2020 American Transplant Congress
Ready for Transplantation: Getting the Right Messages Across at the Right Time
D. Goodall, K. Tansey, S. Clarke-Swaby, P. Webster, E. Salisbury, J. Tomlinson, R. Bright, W. Brown
Imerial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, United Kingdom
*Purpose: Successful outcomes post-transplantation demands significant commitment from patients therefore it is crucial that they have a good understanding of what is involved. Our pharmacist…
2020 American Transplant Congress
Delayed Graft Function Predicts High Risk of Allograft Loss Following Living and Deceased Donor Pediatric Kidney Transplantation
M. MacConmara¹, J. Gattineni¹, D. Desai¹, J. Parekh², P. Vagefi¹, C. S. Hwang¹
¹UT Southwestern, Dallas, TX, ²UC San Diego, San Diego, CA
*Purpose: Pediatric kidney recipients receive high quality living and deceased donor kidneys for transplantation, and as such, these kidneys have a low rate of delayed…
2020 American Transplant Congress
PHS High Risk: Is this Classification Still Needed?
L. G. Smith
Vanderbilt Transplant Center, Nashville, TN
*Purpose: The continued shortage of organs for the over 100,000 candidates on the waitlist has led transplant centers to consider organs that have historically higher…